Target intelligence / Profile preview

10 kDa culture filtrate protein (CFP-10) (CFP-10)

Target
CFP-10
Molecular classification
Virulence factor, Secreted protein, Effector protein, Molecular chaperone, WXG100 family protein
01

Overview

The 10 kDa culture filtrate protein (CFP-10) is a critical virulence factor and secreted antigen produced by Mycobacterium tuberculosis. It belongs to the WXG100 protein family and typically functions as a 1:1 heterodimeric complex with ESAT-6, where CFP-10 serves as a molecular chaperone essential for the stability and secretion of the complex via the ESX-1 (Type VII) secretion system [1, 2, 6]. Once secreted, the complex mediates host-pathogen interactions, specifically facilitating the escape of the bacterium from the macrophage phagosome into the cytosol and modulating host immune responses by inhibiting reactive oxygen species (ROS) and NF-kappaB signaling [7, 11, 13]. CFP-10 also exhibits independent biological activity by binding to a G-protein-coupled receptor on human neutrophils, triggering calcium release and chemotaxis [5]. Because it is encoded in the RD1 genomic region, which is absent in the M. bovis BCG vaccine strain, CFP-10 is a primary diagnostic target in interferon-gamma release assays (IGRAs) used to distinguish TB infection from prior vaccination [9, 14]. Current therapeutic research is exploring CFP-10 as a target for novel anti-virulence drugs that inhibit its secretion and for therapeutic antibodies that activate macrophage-mediated bacterial killing [12, 16].

Other names
CFP10EsxBL-ESAT-6MTSA-1010 kDa culture filtrate antigenSecreted antigenic protein MTSA-10ESAT-6-like protein EsxB
02

Mechanism of action

Stimulates host T-cells to release interferon-gamma for diagnostic detection; as a virulence factor, it complexes with ESAT-6 to disrupt host membranes and evade immune responses; experimental inhibitors block its interaction with the ESX-1 secretion machinery to attenuate bacterial virulence [1, 5, 8, 12].

03

Biological functions

VirulenceHost-pathogen interactionPhagosome escapeImmune evasionNeutrophil activationChemotaxisMacrophage modulationMolecular chaperone
04

Disease associations

InfectionTuberculosis
05

Safety considerations

Cross-reactivity with non-tuberculous mycobacteria (e.g., M. marinum, M. kansasii)Reduced diagnostic specificity in regions endemic for leprosy (due to M. leprae orthologs)Potential for immune-mediated pathology if over-stimulated
06

Interacting drugs

IMB-BZ (Experimental)

1 more in the full profile.

07

Biomarkers

Interferon-gamma release assay (IGRA)QuantiFERON-TB GoldT-SPOT.TBCFP-10 skin testAnti-CFP-10 IgG levels

Beyond the preview

Go deeper on 10 kDa culture filtrate protein (CFP-10) (CFP-10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 10 kDa culture filtrate protein (CFP-10) (CFP-10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call